Children using the low glucose suspend feature in Medtronic's Paradigm Veo, a sensor-based insulin pump system with continuous glucose monitoring, had a lower risk of hypoglycemia without the risk of hyperglycemia and ketoacidosis, German researchers found. The feature reduced the amount of time spent with low blood glucose levels by up to 50%, experts said.

Related Summaries